Aug 13 (Reuters) - Impression Healthcare Ltd IHL.AX :
* IMPRESSION HEALTHCARE ANNOUNCES COMMENCEMENT OF PHASE 2A CLINICAL TRIAL FOR OBSTRUCTIVE SLEEP APNOEA USING "IHL-42X" MEDICINAL CANNABIS FORMULATION
* IMPRESSION HEALTHCARE LTD - SECONDARY OUTCOME MEASURES OF STUDY FOCUSED ON SLEEP QUALITY AND PATIENT MOOD